In the United States during the week ended Dec. 20, someone died from Covid-19 every 33 seconds.
The U.S. Congress approved an $892 billion coronavirus aid package, throwing a lifeline to the nation’s pandemic-battered economy after months of inaction, while also keeping the federal government funded.
The World Health Organization cautioned against major alarm over a new, highly infectious variant of the coronavirus that has emerged in Britain, saying this was a normal part of a pandemic’s evolution.
Countries across the globe shut their borders to Britain on Dec. 21 due to fears about a highly infectious new coronavirus strain, causing travel chaos and raising the prospect of food shortages days before Britain is set to leave the European Union.
Europe’s medicines regulator approved the use of the Covid-19 vaccine developed by U.S. company Pfizer and its German partner BioNTech, putting the EU on course to start inoculations within a week.
The first injections of Moderna’s Covid-19 vaccine started to be administered on Dec. 21 after the U.S. Food and Drug Administration granted Emergency Use Authorization (EUA) on Dec. 18.
Patient communications are no longer fit for purpose, and although Covid has brought this to the fore, the problems will continue for a long time after the vaccine roll-out if they are not resolved.
The European Commission approved Aimmune Therapeutics Inc.’s Palforzia for the treatment of peanut allergy.
The United States is monitoring the new strain of Covid-19 emerging in the United Kingdom, with U.S. officials unclear whether the mutated variant had made its way to America.
A third vaccine to stave off Covid-19 could get U.S. approval as early as January, a top U.S. health official said as the second vaccine began shipping out nationwide..
